Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial

Melissa Cambron; Jop Mostert; Marie D'Hooghe; Guy Nagels; Barbara Willkens; Jan Debruyne; Luc Algoed; Winn Verhagen; Raymond Hupperts; Dorothea Heersema; Jacques De Keyser; Liesbeth De Groot; Erwin Foselle; Daniel Guillaume; Henri Merckx; Ludo Vanopdenbosch; Mathieu Vokaer; Nina De Klippel; Dirk Nuytten; Ann Van Remoortel; Anoek Symons; Miguel D'haeseleer; Veronique Bissay; Annick Van Merhaegen-Wieleman; Michel Van Lint; Veronique Michiels; Patrick Haentjens; Bart Van Wijmeersch; Bart Tillemans; Wim Van Hecke; Gerald Hengstman; FLUOX-PMS Study Group

doi:10.1177/1352458519843051

Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial

Melissa Cambron, Jop Mostert, Marie D'Hooghe, Guy Nagels, Barbara Willkens, Jan Debruyne, Luc Algoed, Winn Verhagen, Raymond Hupperts, Dorothea Heersema, Jacques De Keyser^*, Liesbeth De Groot, Erwin Foselle, Daniel Guillaume, Henri Merckx, Ludo Vanopdenbosch, Mathieu Vokaer, Nina De Klippel, Dirk Nuytten, Ann Van RemoortelAnoek Symons, Miguel D'haeseleer, Veronique Bissay, Annick Van Merhaegen-Wieleman, Michel Van Lint, Veronique Michiels, Patrick Haentjens, Bart Van Wijmeersch, Bart Tillemans, Wim Van Hecke, Gerald Hengstman, FLUOX-PMS Study Group

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Web of Science)

Original language	English
Pages (from-to)	1728-1735
Number of pages	8
Journal	Multiple Sclerosis Journal
Volume	25
Issue number	13
DOIs	https://doi.org/10.1177/1352458519843051
Publication status	Published - Nov 2019

Keywords

Multiple sclerosis
progressive multiple sclerosis
clinical trial
fluoxetine
outcome
neuroprotection
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
DOUBLE-BLIND

Access to Document

10.1177/1352458519843051

Cite this

Cambron, M., Mostert, J., D'Hooghe, M., Nagels, G., Willkens, B., Debruyne, J., Algoed, L., Verhagen, W., Hupperts, R., Heersema, D., De Keyser, J., De Groot, L., Foselle, E., Guillaume, D., Merckx, H., Vanopdenbosch, L., Vokaer, M., De Klippel, N., Nuytten, D., ... FLUOX-PMS Study Group (2019). Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial. Multiple Sclerosis Journal, 25(13), 1728-1735. https://doi.org/10.1177/1352458519843051

Cambron, Melissa ; Mostert, Jop ; D'Hooghe, Marie ; Nagels, Guy ; Willkens, Barbara ; Debruyne, Jan ; Algoed, Luc ; Verhagen, Winn ; Hupperts, Raymond ; Heersema, Dorothea ; De Keyser, Jacques ; De Groot, Liesbeth ; Foselle, Erwin ; Guillaume, Daniel ; Merckx, Henri ; Vanopdenbosch, Ludo ; Vokaer, Mathieu ; De Klippel, Nina ; Nuytten, Dirk ; Van Remoortel, Ann ; Symons, Anoek ; D'haeseleer, Miguel ; Bissay, Veronique ; Van Merhaegen-Wieleman, Annick ; Van Lint, Michel ; Michiels, Veronique ; Haentjens, Patrick ; Van Wijmeersch, Bart ; Tillemans, Bart ; Van Hecke, Wim ; Hengstman, Gerald ; FLUOX-PMS Study Group. / Fluoxetine in progressive multiple sclerosis : The FLUOX-PMS trial. In: Multiple Sclerosis Journal. 2019 ; Vol. 25, No. 13. pp. 1728-1735.

@article{372d8f8c3e5f4321bdcbea7f1c5f65d7,

title = "Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial",

keywords = "Multiple sclerosis, progressive multiple sclerosis, clinical trial, fluoxetine, outcome, neuroprotection, EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, DOUBLE-BLIND",

author = "Melissa Cambron and Jop Mostert and Marie D'Hooghe and Guy Nagels and Barbara Willkens and Jan Debruyne and Luc Algoed and Winn Verhagen and Raymond Hupperts and Dorothea Heersema and {De Keyser}, Jacques and {De Groot}, Liesbeth and Erwin Foselle and Daniel Guillaume and Henri Merckx and Ludo Vanopdenbosch and Mathieu Vokaer and {De Klippel}, Nina and Dirk Nuytten and {Van Remoortel}, Ann and Anoek Symons and Miguel D'haeseleer and Veronique Bissay and {Van Merhaegen-Wieleman}, Annick and {Van Lint}, Michel and Veronique Michiels and Patrick Haentjens and {Van Wijmeersch}, Bart and Bart Tillemans and {Van Hecke}, Wim and Gerald Hengstman and {FLUOX-PMS Study Group}",

year = "2019",

month = nov,

doi = "10.1177/1352458519843051",

language = "English",

volume = "25",

pages = "1728--1735",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "13",

}

Cambron, M, Mostert, J, D'Hooghe, M, Nagels, G, Willkens, B, Debruyne, J, Algoed, L, Verhagen, W, Hupperts, R, Heersema, D, De Keyser, J, De Groot, L, Foselle, E, Guillaume, D, Merckx, H, Vanopdenbosch, L, Vokaer, M, De Klippel, N, Nuytten, D, Van Remoortel, A, Symons, A, D'haeseleer, M, Bissay, V, Van Merhaegen-Wieleman, A, Van Lint, M, Michiels, V, Haentjens, P, Van Wijmeersch, B, Tillemans, B, Van Hecke, W, Hengstman, G & FLUOX-PMS Study Group 2019, 'Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial', Multiple Sclerosis Journal, vol. 25, no. 13, pp. 1728-1735. https://doi.org/10.1177/1352458519843051

Fluoxetine in progressive multiple sclerosis : The FLUOX-PMS trial. / Cambron, Melissa; Mostert, Jop; D'Hooghe, Marie; Nagels, Guy; Willkens, Barbara; Debruyne, Jan; Algoed, Luc; Verhagen, Winn; Hupperts, Raymond; Heersema, Dorothea; De Keyser, Jacques; De Groot, Liesbeth; Foselle, Erwin; Guillaume, Daniel; Merckx, Henri; Vanopdenbosch, Ludo; Vokaer, Mathieu; De Klippel, Nina; Nuytten, Dirk; Van Remoortel, Ann; Symons, Anoek; D'haeseleer, Miguel; Bissay, Veronique; Van Merhaegen-Wieleman, Annick; Van Lint, Michel; Michiels, Veronique; Haentjens, Patrick; Van Wijmeersch, Bart; Tillemans, Bart; Van Hecke, Wim; Hengstman, Gerald; FLUOX-PMS Study Group.

In: Multiple Sclerosis Journal, Vol. 25, No. 13, 11.2019, p. 1728-1735.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Fluoxetine in progressive multiple sclerosis

T2 - The FLUOX-PMS trial

AU - Cambron, Melissa

AU - Mostert, Jop

AU - D'Hooghe, Marie

AU - Nagels, Guy

AU - Willkens, Barbara

AU - Debruyne, Jan

AU - Algoed, Luc

AU - Verhagen, Winn

AU - Hupperts, Raymond

AU - Heersema, Dorothea

AU - De Keyser, Jacques

AU - De Groot, Liesbeth

AU - Foselle, Erwin

AU - Guillaume, Daniel

AU - Merckx, Henri

AU - Vanopdenbosch, Ludo

AU - Vokaer, Mathieu

AU - De Klippel, Nina

AU - Nuytten, Dirk

AU - Van Remoortel, Ann

AU - Symons, Anoek

AU - D'haeseleer, Miguel

AU - Bissay, Veronique

AU - Van Merhaegen-Wieleman, Annick

AU - Van Lint, Michel

AU - Michiels, Veronique

AU - Haentjens, Patrick

AU - Van Wijmeersch, Bart

AU - Tillemans, Bart

AU - Van Hecke, Wim

AU - Hengstman, Gerald

AU - FLUOX-PMS Study Group

PY - 2019/11

Y1 - 2019/11

KW - Multiple sclerosis

KW - progressive multiple sclerosis

KW - clinical trial

KW - fluoxetine

KW - outcome

KW - neuroprotection

KW - EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS

KW - DOUBLE-BLIND

U2 - 10.1177/1352458519843051

DO - 10.1177/1352458519843051

M3 - Article

C2 - 31218911

VL - 25

SP - 1728

EP - 1735

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

SN - 1352-4585

IS - 13

ER -